These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3284109)

  • 21. Excretion of cyclosporine and its metabolites in human bile.
    Burckart GJ; Starzl TE; Venkataramanan R; Hashim H; Wong L; Wang P; Makowka L; Zeevi A; Ptachcinski RJ; Knapp JE
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):46-9. PubMed ID: 3538573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 23. Predominance of native cyclosporine over metabolites in rat blood and tissue.
    Pell MA; Rosano TG; Brayman KL; Freed BM; Shaw LM; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):674-9. PubMed ID: 3363664
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance.
    Copeland KR; Yatscoff RW; McKenna RM
    Clin Chem; 1990 Feb; 36(2):225-9. PubMed ID: 2137384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and comparison of radioimmunoassay methods using monoclonal or polyclonal antibodies for the assay of cyclosporine in blood samples.
    Zucchelli GC; Clerico A; Pilo A; Masini S; Zoppi F; Bovati ML; Gazzetti P; Giovannini L; Bertelli AA
    Int J Tissue React; 1989; 11(6):315-20. PubMed ID: 2699881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of the determination of cyclosporin circulating levels].
    Clerico A; Zucchelli GC
    Minerva Med; 1992; 83(1-2):1-8. PubMed ID: 1545917
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for abnormal cyclosporine A metabolite concentrations.
    Offermann G; Brockmöller J; Kunzendorf U; Roots I
    Transplant Proc; 1989 Feb; 21(1 Pt 1):892-4. PubMed ID: 2650291
    [No Abstract]   [Full Text] [Related]  

  • 28. [Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation].
    Hamilton G; Roth E; Mühlbacher F; Funovics J; Piza F; Schindler J; Woloszcuk W; Havel M; Laczkovics A
    Wien Klin Wochenschr; 1986 Dec; 98(24):820-4. PubMed ID: 3548080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid-chromatographic measurement of cyclosporin A and its metabolites in blood, bile, and urine.
    Christians U; Zimmer KO; Wonigeit K; Maurer G; Sewing KF
    Clin Chem; 1988 Jan; 34(1):34-9. PubMed ID: 3276417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients.
    Gibbons S; Grevel J; Reynolds K; Ried M; Rutzky LP; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):339-44. PubMed ID: 3284077
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and identification of a novel human metabolite of cyclosporin A: dihydro-CsA M17.
    Meier GP; Park SB; Yee GC; Gmur DJ
    Drug Metab Dispos; 1990; 18(1):68-71. PubMed ID: 1970780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific and nonspecific monoclonal 125I-Incstar assays.
    Wong PY; Ma J
    Transplant Proc; 1990 Jun; 22(3):1166-70. PubMed ID: 2349680
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests.
    Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F
    Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality assessment of cyclosporine monitoring--Canadian validations.
    Wong PY; Mee AV; Glenn J; Keown PA
    Transplant Proc; 1990 Jun; 22(3):1216-7. PubMed ID: 2349683
    [No Abstract]   [Full Text] [Related]  

  • 35. An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
    Pesce AJ; Schroeder TJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1171-4. PubMed ID: 2190376
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine serum concentrations soon after heart or heart-lung transplantation.
    Aziz S; Oyer PE; Kates RE
    J Clin Pharmacol; 1986; 26(8):652-7. PubMed ID: 3098805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assessment of cyclosporine measurements: comparison of current methods.
    Holt DW; Marsden JT; Johnston A
    Transplant Proc; 1990 Jun; 22(3):1234-9. PubMed ID: 2190385
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood.
    Ball PE; Munzer H; Keller HP; Abisch E; Rosenthaler J
    Clin Chem; 1988 Feb; 34(2):257-60. PubMed ID: 3277744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients.
    Wang CP; Burckart GJ; Ptachcinski RJ; Venkataramanan R; Schwinghammer T; Hakala T; Griffith B; Hardesty R; Shadduck R; Knapp J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):591-6. PubMed ID: 3284107
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine in auxiliary partial liver transplantation.
    de Rave S; Schalm SW; Willemse PJ; Weimar W; Terpstra OT
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):397-400. PubMed ID: 3291275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.